Market Place
Sourcing Support
Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
05 Jul 2024 //
GLOBENEWSWIRE
Medsenic Signs New Licensing Agreements With Phebra PTY Ltd
02 Jul 2024 //
GLOBENEWSWIRE
Medsenic amends licence agreement with Phebra for arsenic trioxide
30 May 2023 //
PHARMACEUTICAL TECHNOLOGY
BioSenic announces the approval and publication of the Prospectus for listing
08 Feb 2023 //
GLOBENEWSWIRE
A complex fracturing at Bone brings orthopedic biotechs in reverse merger deal
10 Aug 2022 //
FIERCE BIOTECH
Bone Tx broadens portfolio by acquiring majority participation in Medsenic
09 Aug 2022 //
GLOBENEWSWIRE
Medsenic Publishes an Article in Transplantation and Cellular Therapy
18 Jul 2022 //
BUSINESSWIRE
Medsenic gets Positive Pre-IND Response from FDA to Initiate PIII Study in cGvHD
21 Jun 2022 //
BUSINESSWIRE
USPTO Grants Patent to Medsenic`s Arsenic Trioxide in Multiple Sclerosis
29 Sep 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.